HEADER TRANSFERASE 05-JAN-19 6J3P TITLE CRYSTAL STRUCTURE OF THE HUMAN GCN5 BROMODOMAIN IN COMPLEX WITH TITLE 2 COMPOUND (R,R)-36N COMPND MOL_ID: 1; COMPND 2 MOLECULE: HISTONE ACETYLTRANSFERASE KAT2A; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GENERAL CONTROL OF AMINO ACID SYNTHESIS PROTEIN 5-LIKE 2, COMPND 5 HISTONE ACETYLTRANSFERASE GCN5,HGCN5,HISTONE SUCCINYLTRANSFERASE COMPND 6 KAT2A,LYSINE ACETYLTRANSFERASE 2A,STAF97; COMPND 7 EC: 2.3.1.48,2.3.1.-; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KAT2A, GCN5, GCN5L2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CRYSTAL STRUCTURE OF THE HUMAN GCN5 BROMODOMAIN IN COMPLEX WITH KEYWDS 2 COMPOUND (R, R)-36N, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR L.Y.HUANG,H.LI,L.NIU,C.Y.WU,Y.M.YU,L.L.LI,S.Y.YANG REVDAT 3 22-NOV-23 6J3P 1 REMARK REVDAT 2 22-MAY-19 6J3P 1 JRNL REVDAT 1 01-MAY-19 6J3P 0 JRNL AUTH L.HUANG,H.LI,L.LI,L.NIU,R.SEUPEL,C.WU,W.CHENG,C.CHEN,B.DING, JRNL AUTH 2 P.E.BRENNAN,S.YANG JRNL TITL DISCOVERY OF PYRROLO[3,2- D]PYRIMIDIN-4-ONE DERIVATIVES AS A JRNL TITL 2 NEW CLASS OF POTENT AND CELL-ACTIVE INHIBITORS OF JRNL TITL 3 P300/CBP-ASSOCIATED FACTOR BROMODOMAIN. JRNL REF J.MED.CHEM. V. 62 4526 2019 JRNL REFN ISSN 0022-2623 JRNL PMID 30998845 JRNL DOI 10.1021/ACS.JMEDCHEM.9B00096 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.14RC3_3199) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.11 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 34284 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.156 REMARK 3 R VALUE (WORKING SET) : 0.155 REMARK 3 FREE R VALUE : 0.181 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.810 REMARK 3 FREE R VALUE TEST SET COUNT : 1991 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.1258 - 3.8508 1.00 2479 154 0.1751 0.1981 REMARK 3 2 3.8508 - 3.0568 1.00 2367 144 0.1573 0.1773 REMARK 3 3 3.0568 - 2.6705 1.00 2342 153 0.1548 0.1611 REMARK 3 4 2.6705 - 2.4264 1.00 2331 138 0.1565 0.2030 REMARK 3 5 2.4264 - 2.2525 1.00 2306 144 0.1397 0.1855 REMARK 3 6 2.2525 - 2.1197 1.00 2313 139 0.1423 0.1675 REMARK 3 7 2.1197 - 2.0136 1.00 2286 146 0.1489 0.1608 REMARK 3 8 2.0136 - 1.9259 1.00 2307 144 0.1452 0.1737 REMARK 3 9 1.9259 - 1.8518 1.00 2295 138 0.1526 0.1921 REMARK 3 10 1.8518 - 1.7879 1.00 2291 139 0.1491 0.1782 REMARK 3 11 1.7879 - 1.7320 1.00 2273 141 0.1429 0.1830 REMARK 3 12 1.7320 - 1.6825 1.00 2254 145 0.1457 0.1808 REMARK 3 13 1.6825 - 1.6382 1.00 2295 140 0.1453 0.1811 REMARK 3 14 1.6382 - 1.5982 0.95 2154 126 0.1598 0.1994 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.120 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 16.230 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.017 1900 REMARK 3 ANGLE : 1.468 2579 REMARK 3 CHIRALITY : 0.080 264 REMARK 3 PLANARITY : 0.011 323 REMARK 3 DIHEDRAL : 15.770 1139 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6J3P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 22-JAN-19. REMARK 100 THE DEPOSITION ID IS D_1300010408. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-NOV-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL18U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97930 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34345 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.598 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 12.80 REMARK 200 R MERGE (I) : 0.09900 REMARK 200 R SYM (I) : 0.09900 REMARK 200 FOR THE DATA SET : 30.1670 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.66 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.46300 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5MLJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM ACETATE, 0.1 M TRIS PH REMARK 280 8.5, 25% W/V POLYETHYLENE GLYCOL 3,350, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.78600 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.11100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.54600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 38.11100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.78600 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.54600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 703 REMARK 465 HIS A 704 REMARK 465 HIS A 705 REMARK 465 HIS A 706 REMARK 465 HIS A 707 REMARK 465 HIS A 708 REMARK 465 HIS A 709 REMARK 465 SER A 710 REMARK 465 SER A 711 REMARK 465 GLY A 712 REMARK 465 VAL A 713 REMARK 465 ASP A 714 REMARK 465 LEU A 715 REMARK 465 GLY A 716 REMARK 465 THR A 717 REMARK 465 GLU A 718 REMARK 465 ASN A 719 REMARK 465 LEU A 720 REMARK 465 TYR A 721 REMARK 465 PHE A 722 REMARK 465 GLN A 723 REMARK 465 SER A 724 REMARK 465 MET A 725 REMARK 465 GLU A 726 REMARK 465 LEU A 727 REMARK 465 LYS A 728 REMARK 465 LYS A 837 REMARK 465 MET B 703 REMARK 465 HIS B 704 REMARK 465 HIS B 705 REMARK 465 HIS B 706 REMARK 465 HIS B 707 REMARK 465 HIS B 708 REMARK 465 HIS B 709 REMARK 465 SER B 710 REMARK 465 SER B 711 REMARK 465 GLY B 712 REMARK 465 VAL B 713 REMARK 465 ASP B 714 REMARK 465 LEU B 715 REMARK 465 GLY B 716 REMARK 465 THR B 717 REMARK 465 GLU B 718 REMARK 465 ASN B 719 REMARK 465 LEU B 720 REMARK 465 TYR B 721 REMARK 465 PHE B 722 REMARK 465 GLN B 723 REMARK 465 SER B 724 REMARK 465 MET B 725 REMARK 465 GLU B 726 REMARK 465 LEU B 727 REMARK 465 LYS B 728 REMARK 465 ASP B 729 REMARK 465 PRO B 730 REMARK 465 LEU B 834 REMARK 465 ILE B 835 REMARK 465 ASP B 836 REMARK 465 LYS B 837 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU B 813 NH1 ARG B 816 2.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 781 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 ARG B 816 NE - CZ - NH1 ANGL. DEV. = -3.2 DEGREES REMARK 500 ARG B 816 NE - CZ - NH2 ANGL. DEV. = 4.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA B 762 82.61 -160.42 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue B8O A 900 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue B8O B 900 DBREF 6J3P A 726 837 UNP Q92830 KAT2A_HUMAN 726 837 DBREF 6J3P B 726 837 UNP Q92830 KAT2A_HUMAN 726 837 SEQADV 6J3P MET A 703 UNP Q92830 INITIATING METHIONINE SEQADV 6J3P HIS A 704 UNP Q92830 EXPRESSION TAG SEQADV 6J3P HIS A 705 UNP Q92830 EXPRESSION TAG SEQADV 6J3P HIS A 706 UNP Q92830 EXPRESSION TAG SEQADV 6J3P HIS A 707 UNP Q92830 EXPRESSION TAG SEQADV 6J3P HIS A 708 UNP Q92830 EXPRESSION TAG SEQADV 6J3P HIS A 709 UNP Q92830 EXPRESSION TAG SEQADV 6J3P SER A 710 UNP Q92830 EXPRESSION TAG SEQADV 6J3P SER A 711 UNP Q92830 EXPRESSION TAG SEQADV 6J3P GLY A 712 UNP Q92830 EXPRESSION TAG SEQADV 6J3P VAL A 713 UNP Q92830 EXPRESSION TAG SEQADV 6J3P ASP A 714 UNP Q92830 EXPRESSION TAG SEQADV 6J3P LEU A 715 UNP Q92830 EXPRESSION TAG SEQADV 6J3P GLY A 716 UNP Q92830 EXPRESSION TAG SEQADV 6J3P THR A 717 UNP Q92830 EXPRESSION TAG SEQADV 6J3P GLU A 718 UNP Q92830 EXPRESSION TAG SEQADV 6J3P ASN A 719 UNP Q92830 EXPRESSION TAG SEQADV 6J3P LEU A 720 UNP Q92830 EXPRESSION TAG SEQADV 6J3P TYR A 721 UNP Q92830 EXPRESSION TAG SEQADV 6J3P PHE A 722 UNP Q92830 EXPRESSION TAG SEQADV 6J3P GLN A 723 UNP Q92830 EXPRESSION TAG SEQADV 6J3P SER A 724 UNP Q92830 EXPRESSION TAG SEQADV 6J3P MET A 725 UNP Q92830 EXPRESSION TAG SEQADV 6J3P MET B 703 UNP Q92830 INITIATING METHIONINE SEQADV 6J3P HIS B 704 UNP Q92830 EXPRESSION TAG SEQADV 6J3P HIS B 705 UNP Q92830 EXPRESSION TAG SEQADV 6J3P HIS B 706 UNP Q92830 EXPRESSION TAG SEQADV 6J3P HIS B 707 UNP Q92830 EXPRESSION TAG SEQADV 6J3P HIS B 708 UNP Q92830 EXPRESSION TAG SEQADV 6J3P HIS B 709 UNP Q92830 EXPRESSION TAG SEQADV 6J3P SER B 710 UNP Q92830 EXPRESSION TAG SEQADV 6J3P SER B 711 UNP Q92830 EXPRESSION TAG SEQADV 6J3P GLY B 712 UNP Q92830 EXPRESSION TAG SEQADV 6J3P VAL B 713 UNP Q92830 EXPRESSION TAG SEQADV 6J3P ASP B 714 UNP Q92830 EXPRESSION TAG SEQADV 6J3P LEU B 715 UNP Q92830 EXPRESSION TAG SEQADV 6J3P GLY B 716 UNP Q92830 EXPRESSION TAG SEQADV 6J3P THR B 717 UNP Q92830 EXPRESSION TAG SEQADV 6J3P GLU B 718 UNP Q92830 EXPRESSION TAG SEQADV 6J3P ASN B 719 UNP Q92830 EXPRESSION TAG SEQADV 6J3P LEU B 720 UNP Q92830 EXPRESSION TAG SEQADV 6J3P TYR B 721 UNP Q92830 EXPRESSION TAG SEQADV 6J3P PHE B 722 UNP Q92830 EXPRESSION TAG SEQADV 6J3P GLN B 723 UNP Q92830 EXPRESSION TAG SEQADV 6J3P SER B 724 UNP Q92830 EXPRESSION TAG SEQADV 6J3P MET B 725 UNP Q92830 EXPRESSION TAG SEQRES 1 A 135 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 135 GLY THR GLU ASN LEU TYR PHE GLN SER MET GLU LEU LYS SEQRES 3 A 135 ASP PRO ASP GLN LEU TYR THR THR LEU LYS ASN LEU LEU SEQRES 4 A 135 ALA GLN ILE LYS SER HIS PRO SER ALA TRP PRO PHE MET SEQRES 5 A 135 GLU PRO VAL LYS LYS SER GLU ALA PRO ASP TYR TYR GLU SEQRES 6 A 135 VAL ILE ARG PHE PRO ILE ASP LEU LYS THR MET THR GLU SEQRES 7 A 135 ARG LEU ARG SER ARG TYR TYR VAL THR ARG LYS LEU PHE SEQRES 8 A 135 VAL ALA ASP LEU GLN ARG VAL ILE ALA ASN CYS ARG GLU SEQRES 9 A 135 TYR ASN PRO PRO ASP SER GLU TYR CYS ARG CYS ALA SER SEQRES 10 A 135 ALA LEU GLU LYS PHE PHE TYR PHE LYS LEU LYS GLU GLY SEQRES 11 A 135 GLY LEU ILE ASP LYS SEQRES 1 B 135 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 B 135 GLY THR GLU ASN LEU TYR PHE GLN SER MET GLU LEU LYS SEQRES 3 B 135 ASP PRO ASP GLN LEU TYR THR THR LEU LYS ASN LEU LEU SEQRES 4 B 135 ALA GLN ILE LYS SER HIS PRO SER ALA TRP PRO PHE MET SEQRES 5 B 135 GLU PRO VAL LYS LYS SER GLU ALA PRO ASP TYR TYR GLU SEQRES 6 B 135 VAL ILE ARG PHE PRO ILE ASP LEU LYS THR MET THR GLU SEQRES 7 B 135 ARG LEU ARG SER ARG TYR TYR VAL THR ARG LYS LEU PHE SEQRES 8 B 135 VAL ALA ASP LEU GLN ARG VAL ILE ALA ASN CYS ARG GLU SEQRES 9 B 135 TYR ASN PRO PRO ASP SER GLU TYR CYS ARG CYS ALA SER SEQRES 10 B 135 ALA LEU GLU LYS PHE PHE TYR PHE LYS LEU LYS GLU GLY SEQRES 11 B 135 GLY LEU ILE ASP LYS HET B8O A 900 29 HET B8O B 900 29 HETNAM B8O 2-{[(3R,5R)-5-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-1- HETNAM 2 B8O METHYLPIPERIDIN-3-YL]AMINO}-3-METHYL-3,5-DIHYDRO-4H- HETNAM 3 B8O PYRROLO[3,2-D]PYRIMIDIN-4-ONE FORMUL 3 B8O 2(C21 H25 N5 O3) FORMUL 5 HOH *286(H2 O) HELIX 1 AA1 ASP A 729 HIS A 747 1 19 HELIX 2 AA2 PRO A 748 MET A 754 5 7 HELIX 3 AA3 ASP A 764 ILE A 769 1 6 HELIX 4 AA4 ASP A 774 SER A 784 1 11 HELIX 5 AA5 THR A 789 ASN A 808 1 20 HELIX 6 AA6 SER A 812 GLY A 832 1 21 HELIX 7 AA7 GLN B 732 SER B 746 1 15 HELIX 8 AA8 ALA B 750 MET B 754 5 5 HELIX 9 AA9 ASP B 764 ILE B 769 1 6 HELIX 10 AB1 ASP B 774 SER B 784 1 11 HELIX 11 AB2 THR B 789 ASN B 808 1 20 HELIX 12 AB3 SER B 812 GLY B 832 1 21 SITE 1 AC1 9 TRP A 751 PRO A 752 PRO A 756 VAL A 757 SITE 2 AC1 9 GLU A 761 ASN A 808 TYR A 814 HOH A1013 SITE 3 AC1 9 HOH A1020 SITE 1 AC2 10 TRP B 751 PRO B 752 PRO B 756 VAL B 757 SITE 2 AC2 10 GLU B 761 TYR B 807 ASN B 808 TYR B 814 SITE 3 AC2 10 HOH B1015 HOH B1051 CRYST1 45.572 73.092 76.222 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021943 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013681 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013120 0.00000